诺沃诺迪斯克制药技术公司计划在丹麦建造一个220.83亿美元的设施,用于慢性病药品生产,定于2027年运营。 Novo Nordisk Pharmatech plans to build a $220.83m facility in Denmark for chronic disease medicine production, set to operate in 2027.

诺沃诺迪斯克制药技术公司计划在丹麦建造一个220.83亿美元的设施,以满足对慢性病药品日益增长的需求。 Novo Nordisk Pharmatech plans to construct a $220.83m facility in Denmark to meet increased demand for chronic disease medicines. 1.5bn丹麦克朗工厂定于2027年投入使用,它将生产诺沃诺迪斯克毒品的原材料,并创造大约50个新的就业机会。 The 1.5bn Danish crowns plant, set to be operational in 2027, will produce raw materials for Novo Nordisk's drugs and create about 50 new jobs. 该公司是Wegovy和Ozempic等受欢迎待遇的所在地,由于市场资本化,它已成为欧洲最宝贵的公司。 The company, home to popular treatments like Wegovy and Ozempic, has risen to become Europe's most valuable firm by market capitalization.